Safety/Quality

Latest Issue of OR Manager
April 2019
Home Safety/Quality

Effect of hospital intervention, state legislation on postop opioid prescribing practices

Editor's Note After a hospital-wide intervention and state-wide legislation, this community hospital in Michigan achieved a 60%-70% decrease in postoperative opioid prescriptions and less variation in opioid prescription practices. This retrospective study of opioid naïve adult patients who had one of five general surgical procedures between 2015 and 2017 found…

Read More

By: Judy Mathias
March 18, 2019
Share

FDA: Hospira recalls 8.4% Sodium Bicarbonate Injection

Editor's Note The Food and Drug Administration (FDA) on March 15 announced the recall by Hospira, Inc (a Pfizer company) of three lots of its 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL). The recall was initiated because of the presence of particulate matter, confirmed as glass. The…

Read More

By: Judy Mathias
March 18, 2019
Share

Editorial

Attendees at the annual OR Manager Conference have enjoyed the opportunity to ask experienced OR leaders questions about difficult managerial and clinical issues. The popularity of these “Ask Me Anything” sessions reflects the hunger for knowledge about how things are handled in ORs around the country, and they will be…

Read More

By: Elizabeth Wood
March 15, 2019
Share

'Coming clean' in the SPD requires collaboration and competency--Part 1

Contaminated surgical instruments made ECRI Institute’s 2019 annual top 10 list of health technology hazards, coming in at number five: “Mishandling flexible endoscopes after disinfection can lead to patient infections.” Number two on the list in 2018 was “Endoscope reprocessing failures continue to expose patients to infection risk.” It’s not…

Read More

By: Cynthia Saver, MS, RN
March 15, 2019
Share

Prioritizing patient safety unites and empowers OR team--Part 2

Several never events at The Medical Center of Aurora (TMCA) in Aurora, Colorado, over a 1-year period prompted leaders there to launch patient safety first (PSF) initiatives. Part 1 of this series discussed how these initiatives were identified and implemented, and the importance of evidence-based communication tools (OR Manager, March…

Read More

By: Iris Llewellyn
March 15, 2019
Share

Protective garments get makeover in new cleaning protocol

Surgical site infections are multifactorial, and perioperative leaders often struggle with how to reduce or eliminate them. In 2013, after an unexplained increase in surgical site infections (SSIs) among patients undergoing total hip arthroplasty at our facility, we began to investigate the cause. A fairly robust ERAS (enhanced recovery after…

Read More

By: Rhonda L. Anders
March 15, 2019
Share

No increased risk of complications after ambulatory total joint procedures

Editor's Note There were no increased risks of complications or readmissions after total hip replacements (THRs) and total knee replacements (TKRs) performed in a community-based ambulatory surgery center (ASC), finds this study reported in a Poster Session March 14 at the American Academy of Orthopaedic Surgeons in Las Vegas. A…

Read More

By: Judy Mathias
March 14, 2019
Share

Joint Commission releases 2018 sentinel event stats

Editor's Note The Joint Commission on March 13 released its sentinel event statistics for 2018, the majority of which were voluntarily reported by an accredited or certified organization. Of the 10 most frequently reported events, falls and unintended retention of a foreign body were at the top with 111 reports…

Read More

By: Judy Mathias
March 14, 2019
Share

ACDF can be performed safely in outpatient setting

Editor's Note Removal of multiple herniated or degenerative discs in the neck, known as anterior cervical discectomy and fusion (ACDF), can be safely performed in an outpatient setting, finds this study presented March 13 at the American Academy of Orthopaedic Surgeons in Las Vegas. Of 103 patients included in the…

Read More

By: Judy Mathias
March 14, 2019
Share

FDA: Guardian Pharmacy ordered to stop producing sterile compounded drugs

Editor's Note The Food & Drug Administration on March 12 announced that a federal judge entered a consent decree against Guardian Pharmacy Services (Dallas, Texas) to stop the company from producing compounded drug products intended to be sterile until the company complies with the Federal Food, Drug, and Cosmetic (FD&C)…

Read More

By: Judy Mathias
March 14, 2019
Share
Upcoming Webinars
Live chat by BoldChat